Replies to post #230752 on Biotech Values

[radford]

Thank you! I still read the thread regularly but keep quiet for the most part.

Biorad is an interesting company that for the most part flies under the radar. I have owned them since 1993. Compare their valuation to Qiagen who is being bought by ThermoFisher for 11.5 billion. Biorad has a market value of about 11 billion, no debt, 700 mm cash, and sales of 2.5 billion. They have two major segments-clinical diagnostics (1.5 billion revenues) and life science supply (1 billion revenues). They also have an equity investment in Sartorius, a German life sciences company, which is worth somewhere around 5 billion. Their businesses as well as Sartorius are all growing nicely. I don't know how well their Covid-19 antibody assay will perform, but this is a company with outstanding capabilities and a global reach. Check them out if you are not otherwise familiar with them.

[dewophile]

antibody testing for Covid

The best test I could find in terms of sensitivity and specificity in the point of care setting is the following:

https://hardydiagnostics.com/sars-cov-2/

unfortunately it won't be available until May

Sensitivity at >/= 15 days after onset of symptoms
IgM – 95.7%
IgG – 99.0%
Specificity
IgM – 99%
IgG – 99%